Drug Delivery Collaboration and Licensing Deals 2019-2024

$3,995.00

Drug Delivery Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2019 to 2024

Publication date
November 2024
Number of pages
550+
Product type
Research report
Available formats
PDF document
Report edition
6
SKU
CP2102

Drug Delivery Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the drug delivery deals entered into by the world's leading biopharma companies.

Fully revised and updated, the report provides details of drug delivery deals from 2019 to 2024.

The report provides a detailed understanding and analysis of how and why companies enter drug delivery deals. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. 

The report includes collaboration, development, research and licensing deals.

This report contains a comprehensive listing of 1202 drug delivery deals announced since 2019 including financial terms where available including links to online deal records of actual drug delivery partnering deals as disclosed by the deal parties. In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners.

The initial chapters of this report provide an orientation of drug delivery dealmaking. 

Chapter 1 provides an introduction to the report.

Chapter 2 provides an overview of the trends in drug delivery dealmaking since 2019.

Chapter 3 provides an overview of the leading drug delivery deals since 2019. Deals are listed by headline value.

Chapter 4 provides a comprehensive listing of the top 25 most active companies in drug delivery dealmaking with a brief summary followed by a comprehensive listing of drug delivery deals, as well as contract documents available in the public domain.

Chapter 5 provides a comprehensive and detailed review of drug delivery deals signed and announced since Jan 2019, where a contract document is available in the public domain. 

Chapter 6 provides a comprehensive and detailed review of drug delivery partnering deals signed and announced since Jan 2019. The chapter is organized by specific drug delivery technology type in focus.

The report also includes numerous table and figures that illustrate the trends and activities in drug delivery deal making since 2019.

In addition, a comprehensive deal directory is provided organized by company A-Z, deal type and therapeutic target. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

Key benefits

Drug Delivery Collaboration and Licensing Deals provides the reader with the following key benefits:

•    Understand deal trends since 2019
•    Browse drug delivery collaboration and licensing deals
•    Benchmark analysis – identify market value of transactions
•    Financials terms - upfront, milestone, royalties
•    Directory of deals by company A-Z, deal type and therapy area
•    Leading deals by value
•    Most active dealmakers
•    Identify assets and deal terms for each transaction
•    Access contract documents - insights into deal structures
•    Due diligence - assess suitability of your proposed deal terms for partner companies
•    Save hundreds of hours of research time

Report scope

Drug Delivery Collaboration and Licensing Deals is intended to provide the reader with an in-depth understanding of drug delivery trends and structure of deals entered into by leading biopharma companies worldwide.

Drug Delivery Collaboration and Licensing Deals includes:
•    Trends in drug delivery dealmaking in the biopharma industry
•    Directory of drug delivery deal records covering pharmaceutical and biotechnology
•    The leading drug delivery deals by value
•    Most active drug delivery licensing dealmakers

Drug Delivery Collaboration and Licensing Deals provides comprehensive access to available records for deals, including contract documents where available.

Analyzing contract agreements allows due diligence of:

•    What are the precise rights granted or optioned?
•    What is actually granted by the agreement to the partner company?
•    What exclusivity is granted?
•    What is the payment structure for the deal?
•    How are sales and payments audited?
•    What is the deal term?
•    How are the key terms of the agreement defined?
•    How are IPRs handled and owned?
•    Who is responsible for commercialization?
•    Who is responsible for development, supply, and manufacture?
•    How is confidentiality and publication managed?
•    How are disputes to be resolved?
•    Under what conditions can the deal be terminated?
•    What happens when there is a change of ownership?
•    What sublicensing and subcontracting provisions have been agreed?
•    Which boilerplate clauses does the company insist upon?
•    Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
•    Which jurisdiction does the company insist upon for agreement law?

Drug Delivery Collaboration and Licensing Deals provides the reader with the following key benefits:

•    Understand deal trends since 2019
•    Browse drug delivery collaboration and licensing deals
•    Benchmark analysis – identify market value of transactions
•    Financials terms - upfront, milestone, royalties
•    Directory of deals by company A-Z, deal type and therapy area
•    Leading deals by value
•    Most active dealmakers
•    Identify assets and deal terms for each transaction
•    Access contract documents - insights into deal structures
•    Due diligence - assess suitability of your proposed deal terms for partner companies
•    Save hundreds of hours of research time

Executive Summary

Chapter 1 – Introduction

Chapter 2 – Trends in drug delivery dealmaking
2.1. Introduction
2.2. Drug delivery deals over the years
2.3. Most active drug delivery dealmakers
2.4. Drug delivery deals by deal type
2.5. Drug delivery deals by therapy area
2.6. Drug delivery deals by industry sector
2.7. Deal terms for drug delivery deals
2.7.1 Drug delivery deals headline values
2.7.2 Drug delivery deal upfront payments
2.7.3 Drug delivery deal milestone payments
2.7.4 Drug delivery royalty rates

Chapter 3 – Leading drug delivery deals
3.1. Introduction
3.2. Top drug delivery deals by value

Chapter 4 – Most active drug delivery dealmakers
4.1. Introduction
4.2. Most active drug delivery dealmakers
4.3. Most active drug delivery deals company profiles

Chapter 5 – Drug delivery contracts dealmaking directory
5.1. Introduction
5.2. Drug delivery contracts dealmaking directory

Chapter 6 – Drug delivery dealmaking by technology type

Deal directory

Deal directory – Drug delivery deals by company A-Z
Deal directory – Drug delivery deals by deal type
Deal directory – Drug delivery deals by therapy area

Deal type definitions

About Biopharma Research Ltd    
Current Partnering
Current Agreements
Recent report titles from Current Partnering



Table of figures

Figure 1: Drug delivery deals since 2019
Figure 2: Active drug delivery dealmaking activity – 2019 - 2024
Figure 3: Drug delivery deals by deal type since 2019
Figure 4: Drug delivery deals by therapy area since 2019
Figure 5: Drug delivery deals by industry sector since 2019
Figure 6: Drug delivery deals with a headline value
Figure 7: Drug delivery deals with an upfront value
Figure 8: Drug delivery deals with a milestone value
Figure 9: Drug delivery deals with a royalty rate value
Figure 10: Top drug delivery deals by value since 2019
Figure 11: Most active drug delivery dealmakers 2019 - 2024
Figure 12: Drug delivery deals by technology type since 2019

Pricing options

  • $3,995: single-user (encrypted file - one user/device)
  • $5,995: multi-user (encrypted file - up to 5 users/devices)
  • $7,995: company (unencrypted PDF)

Single and Multi-user license files are encrypted PDF documents. Details of how to access using Javelin3 PDF Reader will be provided at report delivery.

Company license files are not encrypted and can be accessed using a PDF Reader.

A full explanation of license type definitions can be found here.

 

Our guarantee

 

Price promise

We guarantee our prices are competitive. If you find the same report advertised at a lower price within 7 days of purchase, we will refund the difference.

 

Latest report

If an update is published within 30 days of your purchase, you will receive it absolutely free of charge.

 

Serious Security

We take your data and security seriously. See our privacy policy for details of how we manage your data.

 

Sales Support

If you have any questions about your report or are unhappy with the quality, we will do our best to resolve your query. Contact us direct.

3D Medicines, 3SBio, 3T Biosciences, 4D Molecular Therapeutics, 180 Life Sciences, AavantiBio, AAVnerGene, Abbott Laboratories, Abbvie, Abcam, Abeona Therapeutics, Abingworth Life Sciences, Ab Initio, ABL Bio, Abnova, ABVC BioPharma, Acacia Pharma, Academy of Military Medical Sciences (China), Accelerator for Technological Research in Genomic Therapies, Accord Healthcare, ACEA Therapeutics, Acelrx Pharmaceuticals, Acer Therapeutics, Acerus, Aclaris Therapeutics, Actelion, Acuitas Therapeutics, Aculys Pharma, Acumen Pharmaceuticals, Acura Pharmaceuticals, Adamas Pharmaceuticals, Adaptive Phage Therapeutics, Adare Pharma Solutions, Adhera Therapeutics, Admedus, Adverum Biotechnologies, Aegis Life, Aerami Therapeutics, Aerie Pharmaceuticals, Aerogen, Aeromics, AeroRx Therapeutics, Affilogic, Affini-T Therapeutics, Affinia Therapeutics, AFT Pharmaceuticals, AFYX Therapeutics, AGC Biologics, Aggrega Pharma, Aguettant, AIM ImmunoTech, AimMax Therapeutics, Ainos, AIT Therapeutics, Ajax Therapeutics, Akari Therapeutics, Alar Pharmaceuticals, Alaya.bio, Albumedix, Alcon Laboratories, Alcove Manufacturing and Distribution, Alcyone Therapeutics, Aldena Therapeutics, Aldevron, Alessa Therapeutics, Alexion Pharmaceuticals, Alex Therapeutics, Aliada Therapeutics, Alimera Sciences, ALK-Abello, Allay Therapeutics, Allegis Pharmaceuticals, Alliance Pharma, Allied Corp, Allogene Therapeutics, Ally Biotech, Almirall, Alnylam Pharmaceuticals, Alpha Cognition, Alphamab Oncology, Alpha Teknova, Altamira Therapeutics, Altasciences, Alteogen, Altimmune, Altis Biosystems, Altum Pharmaceuticals, Altus Formulation, Aluna, Alzamend Neuro, Ambiopharm, American Renal Associates, Amerigen Pharmaceuticals, Amicus Therapeutics, Amneal Pharmaceuticals, AmplifyBio, Amunix, ANANDA Scientific, Andros Pharmaceuticals, Anew Medical, Angelini Pharma, Anji Pharma, Anova Enterprises, Antares Pharma, Apellis Pharmaceuticals, Apex Ridge Consulting, ApiJect Systems, Aposense, Applied DNA Sciences, APR Applied Pharma Research, Aprecia Pharmaceuticals, AprilBio, AptarGroup, Aptar Pharma, Aquavit Pharmaceuticals, Aquestive Therapeutics, Arbor Biotechnologies, Arctic Vision, Arcturus Therapeutics, Arcutis Biotherapeutics, Arecor, argenx, Armata Pharmaceuticals, Arrayus Technologies, ARS Pharmaceuticals, Artios Pharma, Aruvant Sciences, Ascidian Therapeutics, ASC Therapeutics, Asieris MediTech, Asimov, Asklepios Biopharmaceutical, Aspargo Laboratories, Assertio Therapeutics, Astellas Institute for Regenerative Medicine, Astellas Pharma, Astellas Pharma US, AstraZeneca, Athebio, Athenex, Atossa Therapeutics, Attralus, Attwill Medical Solutions, ATUM, Aucta Pharmaceuticals, Audentes Therapeutics, Aura Biosciences, AuraVax Therapeutics, AusHealth, Autotelic, Auxly Cannabis Group, Avance Biosciences, Avance Clinical, Avanos Medical, Avantor, Avectas, Avellino Labs, AviadoBio, Avicanna, Avid Bioservices, Avior Bio, AVIR Pharma, Avista Therapeutics, Avita Therapeutics, Avrobio, AXIM Biotechnologies, Axovant Gene Therapies, Aytu BioPharma, AzurRx BioPharma, Bausch & Lomb, Bausch Health Companies, Bayer, BDD Pharma, Beam Therapeutics, Bebig, Becton Dickinson, Ben-Gurion University, Benuvia Therapeutics, Berkeley Lights, Berkshire Biomedical, Bespoke Gene Therapy Consortium, Beta Bionics, BetterLife Pharma, BevCanna, Bexson Biomedical, Beyond Air, BGN Technologies, Bhami Research, Bharat Biotech, Bial, Bicycle Therapeutics, Bigfoot Biomedical, Bill and Melinda Gates Foundation, Binex, Bio-Techne, Bio-Thera Solutions, Bioarc, biOasis Technologies, BIOASTER, Biobot Surgical, BioCardia, BioComo, BIOCORP, BioCorRx, BioCryst Pharmaceuticals, Biogen, Bioharmony Therapeutics, BioInvent, BioKey, BioLingus, Biological E, BioMarin Pharmaceutical, Biomedical Advanced Research and Development Authority, BioMed X Innovation Center, BiomX, Bionaut Labs, BioNTech, BionX Medical Technologies, BioNxt Solutions, Biopharmaceutical Research Company, BioQ Pharma, BioRAE, Biora Therapeutics, Biorchestra, BioSenic, BioSig Technologies, Biotheus, BioVectra, BioXcel, Birdie Biopharmaceuticals, Blackstone, Bluebird Bio, BlueRock Therapeutics, BlueWillow Biologics, BNC Korea, Boehringer Ingelheim, Bracco Imaging, Brammer Bio, Breath of Life International, Breckenbridge Pharmaceutical, BriaCell Therapeutics, BridgeBio Pharma, Brigham and Women's Hospital, Bristol-Myers Squibb, BRNT, Broad Institute, Bryn Pharma, Cabaletta Bio, Calian Group, Calidi Biotherapeutics, California Institute for Regenerative Medicine, Calyptus Pharmaceuticals, Cambridge Healthcare Innovations, CamDiab, Camurus, CANbridge Pharmaceuticals, Cancer Prevention and Research Institute of Texas, Candela, Candel Therapeutics, Cannabics Pharmaceuticals, Cannaponics, Cannassure Therapeutics, CannPal Animal Therapeutics, Cann Pharmaceutical Australia, CanSinoBIO, Cantabria Pharma, Capillary Biomedical, Capsida Biotherapeutics, Capsigen, Cara Therapeutics, Caravan Biologix, CARB-X, Cardiovascular Systems, CareTaker Medical, Caring Cross, Carisma Therapeutics, Carna BioSciences, Carnegie Mellon University, CarThera, Case Western Reserve University, CASI Pharmaceuticals, Cassiopea, Catalent, CC Biotechnology, Ceapro, Cedars-Sinai Medical Center, Celanese, Cell and Gene Therapy Catapult, Cellares, Cella Therapeutics, Cellevolve Bio, Cellix Bio, Cell Mogrify, Cell Point, Cell Signaling Technology, Cell Therapy Manufacturing Center, Celltrion, Celularity, Center for Breakthrough Medicines, Center for Genomic Regulation, Centre for Commercialization of Regenerative Medicine (CCRM), Centre for Human Drug Research, Cevec Pharmaceuticals, Chansu Vascular Technologies, Charles River Laboratories, Chemesis, Chiesi Farmaceutici, Chiesi Global Rare Diseases, Children's Hospital of Philadelphia, Children's Medical Research Institute, China Grand Pharmaceutical, China Medical System, Chromocell, Chugai Pharmaceutical, CicloMed, Cipher Pharmaceuticals, Cipla, Circassia, Circio, Citius Pharmaceuticals, Citrine Medicine, City of Hope, Civica Rx, ClearPoint Neuro, Clearside Biomedical, Cleveland Clinic, Cleveland University Hospitals, ClinConnect, Clinical Trial and Consulting Services, CliniFusion, CloudCath, CMIC, CMS Aesthetics, CMS Medical, CMT Research Foundation, CN Bio, Coalition for Epidemic Preparedness Innovations, Coastar Therapeutics, Coave Therapeutics, Cobra Biologics, Cocoon Biotech, Codexis, Codiak BioSciences, Colorcon, Columbia University, CombiGene, Comera Life Sciences, Companion Medical, Complix, Conduit Pharmaceuticals, Consegna Pharma, ConserV Bioscience, Context Therapeutics, COPD Foundation, Cornell University, Cornerstone Animal Health, Corning, Cortigent, Cosmo Pharmaceuticals, Covenant Animal Health Partners, Coya Therapeutics, CR Double-Crane, Credence MedSystems, Crescita Therapeutics, CRISPR Therapeutics, Cristalia, Crohn's and Colitis Foundation of America, CROMA Pharma, Cronos Group, CrossBay Medical, Crossject, Crosswalk Therapeutics, Crown Laboratories, CR Pharma, CrystecPharma, CSIRO, CSL, CSL Behring, CS Pharmaceuticals, Cumberland Pharmaceuticals, Curadigm, Cure Genetics, CURE Pharmaceutical, Curigin, Currax Pharmaceuticals, Cutia Therapeutics, Cyagen Biosciences, Cybin, Cycle Pharmaceuticals, Cyclo Therapeutics, Cystic Fibrosis Foundation, Cytoo, Cytovance Biologics, D&D Pharmatech, Daewoong Pharmaceutical, Daiichi Sankyo, Dance Biopharm, Dare Bioscience, DarioHealth, Dartmouth College, DCM, Debiopharm, Decibel Therapeutics, Defense Advanced Research Projects Agency, Defense Health Agency (US), Defense Threat Reduction Agency, DEKA Research and Development, Delpor, DelSiTech, Denali Therapeutics, Department of Defense, Dermira, Desert Medical Campus, DexCom, Diabeloop, DiNAQOR, Diomics, DisperSol Technologies, Diurnal, Dixie State University, Dong-A ST, Dr. Reddy's Laboratories, Dr Bragi Company, Dr Kerklaan Therapeutics, DS Biopharma, DSM, Duke University, Durect, Dyno Therapeutics, Dyve Biosciences, Eagle Pharmaceuticals, Eastman Chemical Company, Editas Medicine, EffRx Pharmaceuticals, EG Gilero, Egis, Ei.Ventures, Eikonoklastes Therapeutics, EirGen Pharma, Eirion Therapeutics, Eisai, Elasmogen, Elcelyx Therapeutics, Elektrofi, ElevateBio, Eleven Biotherapeutics, Eligo Bioscience, Eli Lilly, Elute, Emergex Vaccines, Emery Pharma, Emmaus Life Sciences, Emory University, Empa, Emtora Biosciences, Enable Injections, Enalare Therapeutics, ENA Respiratory, Endo International, Enesi Pharma, Enlivex, Ennaid Therapeutics, Ensoma, Entera Bio, Enteris Biopharma, Entos Pharmaceuticals, Enveric Biosciences, Enzymatica, EPI Health, Erasmus University Medical Center, ErVimmune, EsoCap, Esperovax, Esteve, eTheRNA immunotherapies, Ethris, Ethypharm, Eton Pharmaceuticals, Eunice Kennedy Shriver Institute of Child Health and Human Development, Eurofarma, Eve & Co, Everads Therapy, Evofem Biosciences, Evommune, EVOQ Therapeutics, Evox Therapeutics, Exact Therapeutics, Exeltis, Exonate, Exopharm, Exothera, Expression Therapeutics, EyeCRO, Eyenovia, EyePoint Pharmaceuticals, FairJourney Biologics, Famy Life Sciences, Fareva Holding, Farmalider, Feldan Therapeutics, Felix Biotechnology, Ferndale Pharma Group, First Wave Bio, Flexion Therapeutics, Florabio, Flower One, Fluidda, Fluid Pharma, Fluum, Foamix Pharmaceuticals, Food and Drug Administration (FDA), Forcefield Therapeutics, ForDoz Pharma, Foresee Pharmaceuticals, Forge Biologics, Formosa Pharmaceuticals, Forty Seven, Foundation to Fight H-ABC, Four 20 Pharma, Freeline Therapeutics, FSD Pharma, Fujifilm Diosynth Biotechnologies, Fulcrum Therapeutics, Future Fields, Gaeta Therapeutics, GB Sciences, GC Biopharma, GC Pharma, GE Healthcare, GeneCraft, GenEdit, Genelux, Genenta Science, Genentech, Generation Biotech, Genethon, Genetic Immunity, Genevant Sciences, Genexine, Genezen, Genfit, Genisphere, GenKOre, Genosera, Genovis, Genprex, Gensaic, GenScience Pharmaceuticals, GenScript Biotech, GenScript ProBio, GentiBio, Genuv, Genzyme, Geocann, Georgetown University, GeoVax, Gerresheimer, Getz Healthcare, Ghent University, Giiant Pharma, Gilead Sciences, Ginkgo BioWorks, Gladstone Institutes, Glaukos, Glenmark Pharmaceuticals, Glenmark Pharmaceuticals S.A., Glooko, Glysious, Gradalis, Graviton Bioscience, Greene Street Pharmaceuticals, Grenco Science, Grifols, Gritstone Bio, GSK, GVK Biosciences, GW Pharmaceuticals, Gyroscope Therapeutics, H&T Presspart, Hadassah Medical Center, HaemaLogiX, Haisco Pharmaceutical, HAI Solutions, Halodine, Halozyme Therapeutics, Hangzhou Chance Pharmaceuticals, Hangzhou Zhongmei Huadong Pharmaceutical, Hansa Biopharma, Harm Reduction Therapeutics, Harrow Health, Harvard University, Haselmeier, HCA Healthcare, HCmed Innovations, HDT Bio, Healix, Health2Sync, Hebrew University of Jerusalem, Heqet Therapeutics, Herantis, Higgs Boson Health, High12 Brands, Hikma Pharmaceuticals, Hillstream BioPharma, HLS Therapeutics, Hoffmann La Roche, Hofseth BioCare, Hollister Biosciences, Honeywell, Horizon Therapeutics, Hospital for Special Surgery, Hoth Therapeutics, Hovione, HR Pharmaceuticals, Hunterian Medicine, Huons, Hyloris Pharmaceuticals, Hyphens, Hypospray Pharma, i2c Pharmaceutical Services, i2O Therapeutics, IACTA Pharmaceuticals, Iaso Therapeutics, Icahn School of Medicine at Mount Sinai, ICB Pharma, iCeutica, Ichor Medical Systems, Iconovo, Idorsia, iECURE, IGEA Clinical Biophysics, Ikarovec, Ilera Holistic Healthcare, ImaginAb, Imbrium Therapeutics, Immetas Therapeutics, Immune System Regulation, ImmunGene, ImmunityBio, ImmunoForge, Immunomic Therapeutics, ImmVira, Impel NeuroPharma, Imperial Brands, Imperial College London, Imugene, Incannex Healthcare, Inceptua, Incyte, Indee Labs, Indegene Lifesystems, Indivior, Inexia, Inflammasome Therapeutics, InfuTronix Solutions, iNGENu, Inhalation Sciences, Inhalon Biopharma, InMed Pharmaceuticals, InnarisBio, InnoBation, InnoPharmax, Innosuisse, Innovation Pharmaceuticals, Inovio Pharmaceuticals, InProTher, Inscripta, Inserm, InSightec, InsightRX, InSitu Biologics, Insmed Inc, Inspira Pharmaceuticals, Inspirevax, Institute of Neurodegenerative Diseases, Instituto de Biologia Experimental e Tecnológica, Institut Pasteur, Insulet, INTACT Solutions, Intas Pharmaceuticals, Intec Pharma, Integral Molecular, IntelGenx, Intellego Technologies, Intellia Therapeutics, Intellipharmaceutics, Interbiome, International Vaccine Institute (IVI), Intract Pharma, Intratus, Intravacc, iNtRON Biotechnology, Inventia Healthcare, InvisiShield Technologies, InVixa, Ionis Pharmaceuticals, IriSys, Iroko Pharmaceuticals, Ironwood Pharmaceuticals, iSage Rx, Isosceles Pharmaceuticals, Israeli National Authority for Technological Innovation, iSTAR Medical, Italfarmaco, Itrom Pharmaceutical Group, iVeena Delivery Systems, Ivenix, Iveric Bio, iVexSol, iX Biopharma, Jaeb Center for Health Research Foundation, JanOne, Janssen Biotech, Janssen Pharmaceuticals, Janssen Research & Development, Jasper Therapeutics, Jazz Pharmaceuticals, JCR Pharmaceuticals, Jenner Institute, Jenthera Therapeutics, Jiangsu Aosaikang Pharmaceutical, Jiangsu NHWA Pharmaceutical, Jiangsu Tainuo, Ji Xing Pharmaceuticals, J Molner, Johns Hopkins University, Jolt Health, JOS Pharmaceuticals, Journey Medical, JSC Pharmadis, JSR, Juno Pharmaceuticals Canada, Juno Therapeutics, Juyou Biotechnology, Kaleo, KaliVir Immunotherapeutics, Kalos Therapeutics, Kanabo Research, Karolinska Institute, KBI BioPharma, Kelonia Therapeutics, Kibur Medical, Kindeva Drug Delivery, Kira Pharmaceuticals, Klaria, Komodo Health, Korea Advanced Institute of Science and Technology, Koru Medical Systems, Kowa, Kowa Pharmaceuticals America, Kriya Therapeutics, Kurve Technology, KVK-Tech, Kyowa Hakko Kirin, Kyverna Therapeutics, L-3 Communications, Laboratoires Thea, Laboratorios Ordesa, Laboratory Corporation of America, Lacerta Therapeutics, Laevoroc Oncology, Lannett, Lantheus Holding, Launch Therapeutics, Lawrence Livermore National Laboratory, Lee Moffitt Cancer Center, Leiden University, Leidos, LeMaitre Vascular, Leona M and Harry B Helmsley Charitable Trust, LEO Pharma, Leukocare, LEXEO Therapeutics, Leyden Laboratories, LG Chem, LianBio, Lifecore Biomedical, Life Magnetics, Ligandal, Ligand Pharmaceuticals, Lindy Biosciences, Lineage Cell Therapeutics, LIPAC Oncology, Lipidor, Lipocine, LipoVac, Liuqiang Medical Technology, Livzon Pharmaceutical, Locus Biosciences, LogicBio Therapeutics, Lonza, Lotus Pharmaceuticals, LTS Lohmann Therapie-Systeme, Lubrizol, Lumen Biomedical, Lumenis, Luminary Therapeutics, Lundbeck, Lupagen, Lupin, Luye Pharma Group, Lyndra Therapeutics, Lyra Therapeutics, Lysogene, Macquarie University, Magenta Therapeutics, Magle Chemoswed, Malmo University, Mammoth Biosciences, Mannin Research, MannKind Biopharmaceuticals, Mapi Pharma, Marinomed Biotechnologie, Marinus Pharmaceuticals, Maruho, Maruishi Pharmaceutical, Massachusetts General Hospital, Massachusetts Institute of Technology, Massachusetts Life Sciences Center, Matica Biotechnology, Matinas Biopharma, Maxcyte, Mayo Clinic, MBF Therapeutics, MC2 Therapeutics, McMaster University, MD Anderson Cancer Center, MDimune, Medac, Medherant, MedicaSafe, MediciNova, Medidata Solutions, Medigen Vaccine Biologics, Medigus, MedinCell, Medipal Holdings, MediPharm Labs, Medison Pharma, Medlab Clinical, MedLite ID, Medolife Rx, MedPharm, Medsenic, Medspray, Medtronic, MeiraGTx, Melt Pharmaceuticals, Memorial Sloan Kettering Cancer Center, Menarini, Mentholatum Company, MentiNova, Merck and Co, Merck KGaA, Metagenomi, Meta Healthcare, Microbion, Microbio Shanghai, Micron Biomedical, Microsoft, Midatech Pharma, Mie University, MigVax, Mikart, Milagro Pharmaceuticals, MilliporeSigma, MIM Software, Mind Medicine, Miravo Healthcare, Mirum Pharmaceuticals, Mission Bio, Mitsubishi Chemical, Mitsubishi Tanabe Pharma, Moberg Pharma, Modalis Therapeutics, Moderna, Modular Medical, Molecular Targeting Technologies, MolMed, Monash University, MoonLake Immunotherapeutics, Morgenesis, Mosaic ImmunoEngineering, Mosanna Therapeutics, Mount Sinai Health System, MSD, Mundipharma, Muscular Dystrophy Association, Mustang Bio, Mycrodose Therapeutics, Myeloid Therapeutics, Mylan Laboratories, Myrtelle, Myung In Pharm, Nanexa, Nanite, Nanjing Leads Biolabs, Nanocarry Therapeutics, Nanoform, Nanomerics, Nanommune, Nanopharm, Nano PharmaSolutions, Nanoscope Therapeutics, NanoSmart Pharmaceuticals, Nanotechnology Characterization Laboratory, NaNotics, Nanotronics Health, NanoVation Therapeutics, NantKwest, NantOmics, NapaJen Pharma, Nascent Biotech, National Cancer Institute, National Center for Advancing Translational Sciences (NCATS), National Eye Institute, National Heart, Lung and Blood Institute, National Institute for Environmental Health Sciences, National Institute of Allergy and Infectious Diseases, National Institute of Child Health and Human Development, National Institute of Neurological Disorders and Stroke, National Institute on Drug Abuse (NIDA), National Institutes of Health, National Medical Products, National Research Council Canada, National Resilience, National Science Foundation, Nationwide Children’s Hospital, Navamedic, Navigo Proteins, NEC, NecstGen, Nemaura Pharma, NeoCura Bio-Medical Technology, NeOnc Technologies, Neoregen Biotech, Nephron Dx, Nephron Pharmaceuticals, NE Scientific, NeuCen BioMed, Neumentum, Neuracle Genetics, Neuramedy, Neurelis, Neurgain Technologies, Neurimmune Therapeutics, NeuroBo Pharmaceuticals, Neurochase, Neurocrine Biosciences, Neurophth Therapeutics, NeuroRx, Nevakar, New Age Nanotech, NewBiologix, NewCanna Hub, Newsoara Biopharma, Neximmune, Nextage Therapeutics, Next Generation Manufacturing Canada, Nextleaf Solutions, Nicox, Nicoya, Nirvana Life Sciences, Nivagen Pharmaceuticals, NLS Pharmaceutics, Nocion Therapeutics, Noga Therapeutics, Northeastern University, Northern RNA, Northwestern University, Notable Labs, Nova Mentis Life Science, Novan Therapeutics, Novartis, Novasep, Noveome Biotherapeutics, Novo Nordisk, NRx Pharmaceuticals, NTC, Nuance Pharma, NuMedii, NurExone Biologic, Nuritas, NutraFuels, Nutriband, Nuvothera, NYU Grossman School of Medicine for Preclinical and Clinical Research, NYU Langone Medical Center, Oakrum Pharma, Ocugen, Ocular Therapeutix, Oculis, Oculogenex, Ocumension Therapeutics, Ocuphire Pharma, Omeq Medical, OmniaBio, Oncology Pharma, OncoNano Medicine, Onconova Therapeutics, Oncorus, OncoSec Medical, Oncotelic, Oneness Biotech, ONK Therapeutics, Ono Pharmaceutical, Ophthotech, Opiant Pharmaceuticals, OPKO Biologics, OPKO Health, Optifye Therapeutics, Optimeos Life Sciences, OptiNose, Opus Genetics, Oragenics, Orbis Medicines, Orbit Biomedical, Orchard Therapeutics, Orchestra BioMed, Orexo, Orgenesis, Ori Biotech, ORIC Pharmaceuticals, Orion, Orion Biotechnology, Osivax, Osmotica Pharmaceuticals, OSR Holdings, Ossianix, Oswaldo Cruz Foundation (Fiocruz), Otonomy, Otsuka, Ovation Science, Ovensa, Ovid Therapeutics, Owen Mumford, Oxford BioMedica, Oxford Genetics, Oxgene, Oxyrane UK, Oyster Point Pharma, Palisade Bio, Panaxia, Pancryos, Pantherna Therapeutics, Papyrus Therapeutics, Parexel, Passage Bio, PassPort Technologies, Pax Labs, PeptiDream, Perelman School of Medicine, Persist AI, PersonGen BioTherapeutics, Peter MacCallum Cancer Institute, Pfizer, Phagelux, PharmaIN, PharmaJet, Pharmanovia, Pharma Science, Pharmastrip, Pharmathen, PharmaTher, PharmEnable, Pharos Life Corporation, Phebra, Pherecydes Pharma, Phillips-Medisize, Phio Pharmaceuticals, Photocure ASA, Physiomics, PIC, Picosun, Pieris Pharmaceuticals, PillTracker, Piramal, Planet 13, PlantEXT, Plus Therapeutics, Pneuma Respiratory, Pneuma Systems, Pohang University Of Science And Technology, Poiesis Medical, Polyplus Transfection, Polyrizon, Population Council, Portal Instruments, Poseida Therapeutics, Precise Biometrics, Precision NanoSystems, Precision Virologics, Pregene Biopharma, Pressure BioSciences, Prevail Therapeutics, ProBioGen, Procaps, ProGen Co, Progenity, Prokarium, ProLynx, ProMed Pharma LLC, Propella Therapeutics, Pro Pharmaceuticals, Protalix BioTherapeutics, ProteoNic, ProtoKinetix, Provepharm, Proveris Scientific, PROVIREX Genome Editing Therapies, Psilera, Psycheceutical Bioscience, Pulmatrix, Pulmodyne, Pulmonomy, Pulmotect, Pulmotree Medical, Purdue Pharma, Purnovate, Qinotto, Qnovia, Quoin Pharmaceuticals, QureTech Bio, rAAVen Therapeutics, Radient Technologies, Rafa Laboratories, Rafa Pharmaceuticals, Rallybio, Rambam Medical Center, Rani Therapeutics, Ra Pharmaceuticals, Rapid Dose Therapeutics, Ray Therapeutics, Recipharm, Recordati, Recro Pharma, ReForm Biologics, Regeneron Pharmaceuticals, Regenxbio, ReiThera, ReLeaf Europe, Relief Therapeutics, ReNeuron, RenovoRx, Rentschler Biotechnologie, Rescue Hearing, Resilience, Respira Therapeutics, RespireRx Pharmaceuticals, Resyca, Revive Therapeutics, Reyon Pharmaceuticals, Rhoshan Pharmaceuticals, Rimidi, Ripple Therapeutics, Roche, Rocket Pharmaceuticals, Roivant Sciences, Rokote Laboratories, Roncadelle Operations, Roswell Park Cancer Institute, Rothman Orthopaedic Institute, Rousselot, RS BioTherapeutics, Rubedo Life Sciences, Russian Direct Investment Fund, Rutgers University, Rznomics, Sable Therapeutics, SalioGen Therapeutics, Salus Pharma, Samyang Biopharmaceuticals, Sandoz, Sangamo Therapeutics, Sanofi, SaNOtize Research and Development, Sante Laboratories, Santen Pharmaceutical, Santhera Pharmaceuticals, Sant Joan de Déu-Barcelona Children’s Hospital, SarcoMed USA, Sarepta Therapeutics, Sartorius, Sartorius Stedim Biotech, Satio, Sato Pharmaceutical, Savara Pharma, Scancell, Scandion Oncology, Schott, Schreiner Group, Science Foundation Ireland, Scilex Holding, SciSparc, scPharmaceuticals, SCTbio, Seal Rock Therapeutics, Searchlight Pharma, Seattle Children's Therapeutics, Seattle Childrens Research Institute, Secarna Pharmaceuticals, Seelos Therapeutics, Selecta Biosciences, Sen-Jam Pharmaceutical, Senju Pharmaceutical, Sensei Biotherapeutics, Sensorion, Sensory Cloud, Seqirus, SeraNovo, Serina Therapeutics, Sesen Bio, Seurat Therapeutics, SFC Fluidics, SGN Nanopharma, Shandong Luoxin Pharma, Shanghai Haohai Biological Technology, Shape Therapeutics, Sharps Technology, Shasqi, Shenzhen Beimei Pharmaceuticals, Shenzhen Smoore Technology, Shinshu University, Shionogi, SHL Medical, Showa Denko, SillaJen, Simcere Pharmaceuticals, Simulations Plus, Sino Biological, SipNose, Siren Biotechnology, Sirion Biotech, Sirtex Medical, SiSaf, SiteOne Therapeutics, Skycare Compounding Labs, Skye Bioscience, Skyline Therapeutics, SmartCella, Smiths Medical, SocialDiabetes, Societal CDMO, Sohm, Sol-Gel, Solid Biosciences, Soluble Biotech, Solural Pharma, Solve GNE, SomaServe, Sono-Tek, Sonoma Pharmaceuticals, SonoThera, Sorrel Medical, Sorrento Therapeutics, Sorse Technology, Sosei Heptares, Southwest Research Institute, Spanish National Research Council, SparingVision, Spark Therapeutics, Sparsha, Spectrum Pharmaceuticals, SpineThera, SpliceBio, SQ Innovation, SQZ Biotech, SRI International, STADA Arzneimittel, Stanford University, Starpharma, Starton Therapeutics, St Elizabeth Healthcare, Stevanato, StrideBio, Strides Pharma Science, Strm.Bio, Subcuject, SUDA Pharmaceuticals, Summit Biosciences, Sundial Growers, Sunovion Pharmaceuticals, Sun Pharmaceutical, Suono Bio, Supreme Cannabis, Suzhou NeuPharma, Swedish Bactiguard, Swedish Orphan Biovitrum, Swedish Research Council, Symbiosis, Symvivo, Synairgen, Syntegon, Synthonics, Tabula Rasa HealthCare, Tactical Relief, Taiba, Taisho Pharmaceutical, Taiwan Liposome Company, Takeda Pharmaceutical, TALLC, Tandem Diabetes Care, Targovax, Tautomer Bioscience, Taysha Gene Therapies, TEDOR Pharma, Telix Pharmaceuticals, Temple University, Tenacia Biotechnology, Terumo, Tetherex Pharmaceuticals, Tetra Bio-Pharma, Tetra Pharm Technologies, Teva Pharmaceutical Industries, Texcell, TFF Pharmaceuticals, Tharimmune, The Native Antigen Company, TheracosBio, Theramex, Therapeutics Incorporated, TherapeuticsMD, Therapyx, Theravectys, Theriva Biologics, Thermo Fisher Scientific, Third Pole Therapeutics, Tianjin CanSino Biotechnology, Tiba Biotech, Tidepool, TILT Biotherapeutics, Tioga Research, Titan Pharmaceuticals, TLC BioSciences, Tolmar, TONIX Pharmaceuticals, Torii Pharmaceutical, Toshiba, Towa Pharmaceutical, TransCode Therapeutics, Transcoject, Transfertech Sherbrooke, Transgene, Trevi Therapeutics, Triastek, TriSalus Life Sciences, Tris Pharma, True North Cannabis, TRx Biosciences, TSRL, Turnstone Biologics, Twist Bioscience, Tyligand Bioscience, UCB, UK Government, Ultragenyx Pharmaceuticals, Umoja Biopharma, UNION Therapeutics, UniQuest, UniQure, Univercells, University College Cork, University of Alabama at Birmingham, University of Antwerp, University of Basel, University of California, Davis, University of California Berkeley, University of California San Francisco, University of Chicago, University of Colorado, University of Connecticut, University of Florida, University of Florida Research Foundation, University of Georgia, University of Helsinki, University of Houston, University of Iowa, University of Leipzig, University of Manchester, University of Massachusetts Medical School, University of Miami, University of Minnesota, University of Nebraska, University of New South Wales, University of North Carolina, University of Notre of Dame, University of Oxford, University of Pennsylvania, University of Pennsylvania School of Veterinary Medicine, University of Pittsburg, University of Pittsburgh, University of Prince Edward Island, University of Sheffield, University of Sydney, University of Tennessee, University of Texas, University of Texas Southwestern Medical Center, University of Virginia, University of Wisconsin-Madison, Unnatural Products, Upadia, Uppsalagruppen Medical, Upsher-Smith, UroGen Pharma, US Army, US Army Medical Research and Material Command, US Army Medical Research Institute of Infectious Diseases, US Biologic, US Government, Utrecht University, Vaccinex, Valens Company, Valeo Pharma, Valo Therapeutics, Vapium, Vaxalto Biotherapeutics, Vaxart, Vaxess Technologies, Vaxxas, Vect-Horus, Vector BioMed, Vector BioPharma, VectorBuilder, VectorY Therapeutics, Vectura, Veeva Systems, VerdePharmHealth, Verismo Therapeutics, Verndari, Verrica Pharmaceuticals, Vertex Pharmaceuticals, Verve Therapeutics, Vesselon, Vetter, ViaCyte, ViGeneron, ViiV Healthcare, ViralClear Pharmaceuticals, Viralgen, Vir Biotechnology, Virica Biotech, Viridian Therapeutics, Virpax Pharmaceuticals, Visus Therapeutics, Vitanova Biomedical, Vivani Medical, Vivasc Therapeutics, VIVEbiotech, Vivera Pharmaceuticals, Vivet Therapeutics, Vivtex, Voronoi, Voyager Therapeutics, Vyriad, Wageningen University, Wakamoto Pharmaceutical, Walter Reed Army Institute of Research, Washington University in St Louis, Weizmann Institute, Wellcome Trust, WellDoc, Welton Pharma, Werewolf Therapeutics, West Pharmaceutical Services, WhiteLab Genomics, Windgap Medical, Winhealth Pharma Group, W L Gore, Worldwide Clinical Trials, WUGEN, WuXi Advanced Therapies, Wuxi STA, Wyss Institute, Xanadu Bio, Xellia Pharmaceuticals, Xenon Pharmaceuticals, XERIS Pharmaceuticals, XyloCor Therapeutics, Xyphos Biosciences, Yale Cancer Center, Yale University, Yeda Research and Development Company, Yiling Wanzhou International Pharmaceuticals, Yissum Research Development, Yposkesi, Ypsomed, Zambon, ZappRx, Zealand Pharma, Zerion Pharma, Zhaoke (Hong Kong) Ophthalmology Pharmaceutical, Zion Pharmaceuticals, Ziphius Vaccines, Zosano Pharma, Zylo Therapeutics, ZYUS Life Sciences

Current Partnering reports provide insight into the trends and terms of partnering deals in the global life sciences sector.

Current Partnering reports are updated every six months to ensure the user has access to the latest announcements and trends in the topic focus of the report.

Current Partnering analysts review the deal data to provide an overview and analysis of deal trends, including example deals and terms.

Current Partnering reports source deal data from our proprietary deals and alliances database, Current Agreements. The database is updated daily by our analysts with new deals as they are announced globally by the company’s party to the deal. In addition, deal records are updated with new data as it becomes available.

The data in the Current Agreements deals and alliances database is obtained from secondary sources such as publicly available industry sources including press releases, company presentations, investor presentations, company SEC filings, other company filings, company websites, conference presentations. Sources are identified to allow for user verification.

Current Partnering provides comprehensive coverage of the following partnering or deal types:
• Asset purchase
• Assignment
• Co-development
• Co-market
• Co-promotion
• Collaborative R&D
• Contract service
• CRADA
• Cross-licensing
• Development
• Distribution
• Equity purchase
• Evaluation
• Grant
• Joint venture
• Licensing
• Loan
• Manufacturing
• Marketing
• Option
• Promotion
• Research
• Royalty financing
• Settlement
• Spin out
• Sub license
• Supply
• Termination
• Warrant

Every deal record is fully categorized and includes the following data, where available:
• Industry sector
• Therapy areas
• Technology type
• Deal components
• Financial terms
• Stage of development
• Exclusivity
• Asset type
• Geographic focus
• Excluded geography
• Company press release
• SEC filing data including contract document

All financial amounts are converted to US$ using the exchange rate available on the date of deal announcement, enabling direct comparison of deal terms across international territories.

Financial data and contract documents displayed in deal records is obtained from public sources, where disclosed by the parties to the deal.

We found other products you might like!